Target Price | $165.09 |
Price | $143.82 |
Potential | 14.79% |
Number of Estimates | 23 |
23 Analysts have issued a price target Illumina 2025 . The average Illumina target price is $165.09. This is 14.79% higher than the current stock price. The highest price target is $254.00 76.61% , the lowest is $120.00 16.56% . | |
A rating was issued by 27 analysts: 14 Analysts recommend Illumina to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Illumina stock has an average upside potential 2025 of 14.79% . Most analysts recommend the Illumina stock at Purchase. |
22 Analysts have issued a sales forecast Illumina 2024 . The average Illumina sales estimate is $4.3b . This is 1.69% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $4.3b 1.13% , the lowest is $4.3b 2.17% .
This results in the following potential growth metrics:
2023 | $4.5b | 1.75% |
---|---|---|
2024 | $4.3b | 4.17% |
2025 | $4.5b | 3.95% |
2026 | $4.8b | 6.26% |
2027 | $5.1b | 6.12% |
2028 | $5.4b | 6.30% |
12 Analysts have issued an Illumina EBITDA forecast 2024. The average Illumina EBITDA estimate is $1.2b . This is 14.35% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.5b 10.38% , the lowest is $912m 33.16% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $338m | 54.81% |
---|---|---|
2024 | $1.2b | 245.65% |
2025 | $1.3b | 8.01% |
2026 | $1.4b | 11.66% |
2027 | $1.6b | 15.75% |
2028 | $1.8b | 8.28% |
2023 | 7.50% | 54.01% |
---|---|---|
2024 | 27.07% | 260.72% |
2025 | 28.13% | 3.92% |
2026 | 29.56% | 5.08% |
2027 | 32.24% | 9.07% |
2028 | 32.84% | 1.86% |
6 Illumina Analysts have issued a net profit forecast 2024. The average Illumina net profit estimate is $-1.3b . This is 14.75% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-798m 49.50% , the lowest is $-2.2b 38.30% .
This results in the following potential growth metrics and future Net Margins:
2023 | $-1.2b | 73.80% |
---|---|---|
2024 | $-1.3b | 15.99% |
2025 | $489m | 136.31% |
2026 | $680m | 38.95% |
2027 | $741m | 9.04% |
2028 | $811m | 9.38% |
2023 | -25.78% | 73.33% |
---|---|---|
2024 | -31.21% | 21.05% |
2025 | 10.90% | 134.92% |
2026 | 14.26% | 30.83% |
2027 | 14.65% | 2.73% |
2028 | 15.07% | 2.87% |
6 Analysts have issued a Illumina forecast for earnings per share. The average Illumina <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $-8.53 . This is 14.70% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $-5.05 49.50% , the lowest is $-13.83 38.30% .
This results in the following potential growth metrics and future valuations:
2023 | $-7.35 | 73.80% |
---|---|---|
2024 | $-8.53 | 16.05% |
2025 | $3.10 | 136.34% |
2026 | $4.30 | 38.71% |
2027 | $4.69 | 9.07% |
2028 | $5.13 | 9.38% |
Current | -14.39 | 4.20% |
---|---|---|
2024 | -16.87 | 17.23% |
2025 | 46.46 | 375.40% |
2026 | 33.44 | 28.02% |
2027 | 30.67 | 8.28% |
2028 | 28.04 | 8.58% |
Based on analysts' sales estimates for 2024, the Illumina stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.69 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.29 .
This results in the following potential growth metrics and future valuations:
Current | 5.59 | 47.11% |
---|---|---|
2024 | 5.69 | 1.73% |
2025 | 5.47 | 3.80% |
2026 | 5.15 | 5.89% |
2027 | 4.85 | 5.77% |
2028 | 4.56 | 5.93% |
Current | 5.20 | 48.56% |
---|---|---|
2024 | 5.29 | 1.71% |
2025 | 5.08 | 3.81% |
2026 | 4.78 | 5.89% |
2027 | 4.51 | 5.76% |
2028 | 4.24 | 5.93% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.